Skip to main content
OpenTrials

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,072 public trials 579 recruiting studies
Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Active, Not Recruiting

A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma

NCT05955508

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • Hospital Clinico Universitario Santiago de Compostela Santiago de Compostela, A Coruna, Spain
  • Hospital Universitario Virgen de las Nieves Granada, Andalusia, Spain
  • Hospital Universitari Son Llatzer Palma Mallorca, Balearic Islands, Spain
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
View all 17 locations
View Trial Details
Active, Not Recruiting

Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma

NCT05208086

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Ch Annecy Genevois Annecy, France
  • Centre Hospitalier Métropole de Savoie Chambéry, France
  • CHU François Mitterand Dijon, France
  • CH de Dunkerque Dunkirk, France
View all 18 locations
View Trial Details
Active, Not Recruiting

SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies

NCT04684108

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +20 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Affiliated Beijing Chaoyang Hospital of Capital Medical University Beijing, Beijing Municipality, China
  • Beijing Jishuitan Hostipal Beijing, Beijing Municipality, China
  • Shenzhen Second People's Hospital Shenzhen, Guangzhou, China
View all 14 locations
View Trial Details
Active, Not Recruiting

Compare Lenalidomide and Subcutaneous Daratumumab vs Lenalidomide and Dexamethasone in Frail Subjects With Previously Untreated Multiple Myeloma Who Are Ineligible for High Dose Therapy

NCT03993912

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Chru Jean Minjoz Besançon, France
  • Ch Blois Simone Veil Blois, France
  • Ch Fleyriat Bourg-en-Bresse, France
  • Chru Brest Site Hopital Morvan Brest, France
View all 23 locations
View Trial Details
Active, Not Recruiting

Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

NCT04975997

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 035 Hot Springs, Arkansas, United States
  • Local Institution - 641 Cerritos, California, United States
  • Local Institution - 681 Fountain Valley, California, United States
  • Local Institution - 047 Los Angeles, California, United States
View all 259 locations
View Trial Details

Related conditions